BIOMAT Database Logo BIOMAT Database Logo

[Molecular diagnostics of non-small cell lung cancer: New markers and technologies]. 2015

A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Institut für Pathologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Deutschland.

Lung cancer is the prototypical tumor entity for the development of new diagnostic and individualized therapeutic strategies based on molecular patient stratification. Developments in this field specifically concentrate on predictive biomarkers for the response to conventional therapeutic agents, novel drugs targeting specific mutations and also new immunomodulatory drugs. The multitude of upcoming new predictive biomarkers requires the development and implementation of efficient test strategies and comprehensive technical methods, specifically when tissue restrictions inherent to lung cancer diagnostics are also taken into account. Novel procedures and technical aspects of these issues are discussed in this review.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D057285 Precision Medicine Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile. Individualized Medicine,Predictive Medicine,P Health,P-Health,Personalized Medicine,Theranostics,Medicine, Individualized,Medicine, Personalized,Medicine, Precision,Medicine, Predictive,Theranostic
D025202 Molecular Diagnostic Techniques MOLECULAR BIOLOGY techniques used in the diagnosis of disease. Molecular Testing,Molecular Diagnostic Technics,Molecular Diagnostic Testing,Diagnostic Technic, Molecular,Diagnostic Technics, Molecular,Diagnostic Technique, Molecular,Diagnostic Techniques, Molecular,Diagnostic Testing, Molecular,Molecular Diagnostic Technic,Molecular Diagnostic Technique,Technic, Molecular Diagnostic,Technics, Molecular Diagnostic,Technique, Molecular Diagnostic,Techniques, Molecular Diagnostic,Testing, Molecular,Testing, Molecular Diagnostic

Related Publications

A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
[Cytopathology and molecular diagnostics of non-small cell lung cancer (NSCLC)].
July 2022, Innere Medizin (Heidelberg, Germany),
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Current and future molecular diagnostics in non-small-cell lung cancer.
January 2015, Expert review of molecular diagnostics,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Prognostic molecular markers in non-small cell lung cancer.
December 2001, Lung cancer (Amsterdam, Netherlands),
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Predictive molecular markers in non-small cell lung cancer.
March 2001, Current opinion in oncology,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
[Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
November 2015, Der Pathologe,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Molecular Diagnostics in Non-Small Cell Lung Carcinoma.
June 2020, Seminars in respiratory and critical care medicine,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Molecular genetic tumor markers in non-small cell lung cancer.
January 2005, Anticancer research,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Molecular predictive and prognostic markers in non-small-cell lung cancer.
October 2009, The Lancet. Oncology,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
New challenges for laboratory diagnostics in non-small cell lung cancer.
January 2010, Cancer biomarkers : section A of Disease markers,
A Warth, and V Endris, and M Kriegsmann, and A Stenzinger, and R Penzel, and N Pfarr, and W Weichert
Do molecular markers predict survival in non-small-cell lung cancer?
April 1998, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!